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Francisella tularensis, a gram-negative facultative intracellular bacterial pathogen, causes disseminating
infections in humans and other mammalian hosts. Macrophages and other monocytes have long been consid-
ered the primary site of F. tularensis replication in infected animals. However, recently it was reported that F.
tularensis also invades and replicates within alveolar epithelial cells following inhalation in a mouse model of
tularemia. TC-1 cells, a mouse lung epithelial cell line, were used to study the process of F. tularensis invasion
and intracellular trafficking within nonphagocytic cells. Live and paraformaldehyde-fixed F. tularensis live
vaccine strain organisms associated with, and were internalized by, TC-1 cells at similar frequencies and with
indistinguishable differences in kinetics. Inhibitors of microfilament and microtubule activity resulted in
significantly decreased F. tularensis invasion, as did inhibitors of phosphatidylinositol 3-kinase and tyrosine
kinase activity. Collectively, these results suggest that F. tularensis epithelial cell invasion is mediated by a
preformed ligand on the bacterial surface and driven entirely by host cell processes. Once internalized, F.
tularensis-containing endosomes associated with early endosome antigen 1 (EEA1) followed by lysosome-
associated membrane protein 1 (LAMP-1), with peak coassociation frequencies occurring at 30 and 120 min
postinoculation, respectively. By 2 h postinoculation, 70.0% ( 5.5%) of intracellular bacteria were accessible
to antibody delivered to the cytoplasm, indicating vacuolar breakdown and escape into the cytoplasm.
Francisella tularensis, the causative agent of the disease tu-
laremia, infects a wide range of animal hosts. Humans can be
infected by a variety of routes, including physical contact with
infected animals, insect bites, ingestion of contaminated food
or water, and inhalation of organisms (13, 52). Disease severity
is affected by both the route of inoculation and the bacterial
subtype (13, 48, 52). F. tularensis strains are subdivided into
two groups, A and B; the more severe form of tularemia in
humans is caused by type A strains (13, 48, 52). Type A strain
F. tularensis subspecies tularensis is found almost exclusively in
North America, whereas type B strain F. tularensis subspecies
holarctica is found throughout Europe, as well as in North
America (35). There is a 5% to 15% mortality rate associated
with untreated human tularemia caused by type A strains;
however, that rate reaches 30% to 60% for untreated pneu-
monic and typhoid forms of the disease (11). The live vaccine
strain (LVS) is an attenuated type B strain that causes a tula-
remia-like disease in mice and is used as a model organism to
study F. tularensis pathogenesis. There has been heightened
interest in the study of this organism in recent years due to its
history of weaponization and potential for use as an agent of
biological warfare. F. tularensis is a category A select agent on
the CDC’s bioterrorism agent list, which includes organisms
with the potential to cause high numbers of casualties if dis-
seminated in an aerosol form (26).
Much of the Francisella pathogenesis research has focused
on the survival and replication of F. tularensis in macrophages
and dendritic cells, and many of the genes identified to date
that are required for full virulence contribute to survival or
replication in the macrophage (1, 6, 17, 20, 27, 30, 32, 37, 42).
We recently demonstrated that F. tularensis also invades and
replicates in alveolar type II (ATII) epithelial cells of infected
mice (21). ATII cells have a number of biological functions,
including the production, secretion, and recycling of surfac-
tant; proliferation to produce additional type II cells as well as
transdifferentiation into type I cells; maintenance of alveolar
fluid balance; and production of antimicrobial and anti-inflam-
matory substances (29). Due to their close proximity to endo-
thelial cells and their role in gas exchange and fluid balance,
these cells are ideally located to provide a portal through which
bacteria could disseminate to distal organs.
F. tularensis attaches to and invades nonphagocytic cells,
including the ATII cell lines A549 and MLE 12 and the lung
epithelial cell line TC-1 (21, 28). Melillo et al. also reported
that Escherichia coli expressing the F. tularensis surface protein
FsaP binds to A549 cells (31), identifying a surface protein that
may play a role in ATII cell association.
A primary function of monocytes is to engulf bacterial cells
and other foreign particles (24, 44). However, the invasion of
epithelial and other nonphagocytic host tissue cells requires
bacterially mediated exploitation of host cell functions to gain
entry (10, 15, 16). Alveolar epithelial cells provide a site where
F. tularensis can replicate in the infected host (21), and as such
it is important to understand how bacterial interaction with
these cells may differ from interaction with macrophages.
Herein we describe our efforts to understand how F. tularensis
invades lung epithelial cells.
MATERIALS AND METHODS
Bacterial strains. Francisella tularensis LVS was obtained from the CDC,
Atlanta, GA. LVSgfp was constructed using the pKK214GFP plasmid (a gift of
Mats Forsman). F. tularensis LVS and LVSgfp were propagated on chocolate
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agar supplemented with 1% IsoVitaleX (Becton-Dickinson). Listeria monocyto-
genes EGD1/2a, Salmonella enterica serovar Typhimurium, Yersinia pseudotuber-
culosis, and Campylobacter jejuni strain 81-176 were gifts from Paul Orndorff,
Craig Altier, Ralph Isberg, and Deborah Threadgill, respectively. All bacterial
strains were grown on LB agar, with the exception of C. jejuni, which was grown
on Mueller-Hinton agar with 5% CO2, and F. tularensis LVS, which was grown
on chocolate agar as described above. All bacterial strains were grown at 37°C.
Salmonella enterica was grown overnight in LB broth under static conditions for
invasion assays.
Cell culture. TC-1 (ATCC CRL-2785) is a tumor cell line derived from pri-
mary lung epithelial cells of C57BL/6 mice. The cells were immortalized with
human papillomavirus type 16 E6 and E7 and transformed with the c-H-ras
oncogene. These cells were grown in RPMI 1640 supplemented with 2 mM
L-glutamine, 1.5 g/liter sodium bicarbonate, 10 mM HEPES, 1.0 mM sodium
pyruvate, 0.1 mM nonessential amino acids, and 10% fetal bovine serum. Cell
cultures were maintained at 37°C and 5% CO2.
Attachment, invasion, and vacuolar escape assay. To evaluate the percentage
of TC-1 cells with associated bacteria, synchronized infections were carried
out by adding F. tularensis LVS expressing green fluorescent protein (GFP)
(LVSgfp) at a multiplicity of infection (MOI) of 100 to TC-1 cells chilled to 4°C.
Bacterial suspensions were made in tissue culture media from bacteria grown as
described above. Bacterial concentration of suspensions was determined using a
Klett meter. Dilutions of suspensions were plated to verify MOI. Plates were
centrifuged at 300  g for 5 min at 4°C and then rapidly warmed by placing in a
37°C water bath for 2 min before transferring to a 37°C, 5% CO2 incubator. For
experiments using killed LVS, organisms were treated with 4% paraformalde-
hyde (PFA) for 10 min. There was no growth from a PFA-treated bacterial
aliquot that was plated on chocolate agar, demonstrating that PFA treatment
killed all organisms. At 10 min postinoculation, samples were washed with
phosphate-buffered saline (PBS) to remove unattached bacteria, and prewarmed
medium was added to monolayers. Cells were collected by trypsinization at 10,
20, 30, and 60 min postinoculation and samples were processed at 4°C. Cells to
be analyzed for bacteria association were fixed in 4% PFA for 10 min and
analyzed by flow cytometry.
Parallel wells were analyzed for intracellular bacteria by collecting samples as
described above. Extracellular bacteria were labeled using anti-F. tularensis li-
popolysaccharide (LPS) antibody (USBiological) conjugated to Pacific Blue
(Molecular Probes), 1:1,000, for 30 min at 4°C. Cells were then lysed with water
and centrifuged at 300  g to removed eukaryotic cell debris. Supernatant
containing bacteria was centrifuged at 16,000  g, fixed with 4% PFA, and
analyzed by flow cytometry to differentiate intracellular (GFP only) from extra-
cellular (GFP and Pacific Blue) bacteria.
To evaluate bacterial escape into the cytoplasm, synchronized inoculations of
TC-1 cells and staining of extracellular bacteria were done as described above.
Cells were collected by trypsinization at 10, 20, 30, 60, and 120 min postinocu-
lation. TC-1 cells were treated with 50 g/ml digitonin in KHM buffer (110 mM
potassium acetate-20 mM HEPES-2 mM MgCl2, pH 7.3) for 1 min, washed in
KHM buffer, and incubated with anti-F. tularensis LPS antibody conjugated to
Alexa Fluor 647 (Molecular Probes), 1:1,000, for 30 min at 4°C. Cells were then
washed in KHM buffer, lysed with water, and centrifuged at 300  g to remove
cellular debris. Supernatants were centrifuged at 16,000  g and bacterial pellets
were fixed in 4% PFA and analyzed by flow cytometry to differentiate extracel-
lular (GFP, Pacific Blue, and Alexa Fluor 647), cytoplasmic (GFP and Alexa
Fluor 647), and vacuolar (GFP-only) bacteria.
Flow cytometry of whole cells and bacteria was performed using a CyAn ADP
flow cytometer (Dako Cytomation). Data were analyzed using Summit Software
(Dako), with gating for single events for whole-cell samples and GFP-positive
single events for bacterial samples.
Inhibitor assays. Inhibitor assays were carried out with cytochalasin D, col-
chicine, wortmannin, and genistein. Cytochalasin D, an actin polymerization
inhibitor, was used at 0.5 and 1.0 M concentrations. Colchicine, a microtubule
polymerization inhibitor, was used at 0.1 and 0.25 M concentrations. Wortman-
nin, an inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase) activity, was used
at 100 and 200 nM concentrations. Genistein, an inhibitor of tyrosine kinase
activity, was used at 50 and 100 M concentrations. Monolayers were preincu-
bated for 1 hour with escalating concentrations of inhibitor, and then bacteria
suspended in media containing inhibitor were added at MOI of 100 for LVS or
25 to 50 for other bacteria. Samples without inhibitor included bacteria sus-
pended in tissue culture media alone or in media containing the carrier in which
the inhibitor was reconstituted where appropriate. After 4 hours, cells were
washed with PBS to remove inhibitor. Extracellular bacteria were killed by
adding media containing 25 g/ml of gentamicin and incubated for 2 h before
monolayers were washed with PBS and scraped from the plate using sterile
applicator sticks. Serial dilutions were plated on chocolate agar to quantify CFU
of intracellular bacteria. Inhibitors did not affect LVS viability, as demonstrated
by incubating bacteria in tissue culture media containing inhibitor for 4 hours,
followed by plating onto chocolate agar to quantify CFU. Inhibitors did not affect
eukaryotic cell viability at the concentrations used, as determined by trypan blue
exclusion. The effect of inhibitors on bacterial attachment to cells was deter-
mined as described above for invasion, except that gentamicin was not added,
allowing bacteria attached to cells but not internalized to be included in the CFU
recovered. Inhibitors had no effect on LVS attachment to TC-1 cells. Results are
expressed as the percentage of LVS or control organism that survived gentamicin
treatment, relative to that for the sample without inhibitor inoculated with the
same organism. Invasion without inhibitor is defined as 100% invasion. Data
presented are the results of assays done in triplicate and are representative of
multiple repetitions of each experiment. Data were analyzed for statistical sig-
nificance by paired two-tailed t test and were considered significantly different
from the untreated control when the P value was 0.01.
Fluorescence microscopy. Cells were grown on poly-L-lysine-coated coverslips
in 24-well cell culture plates to 90% confluence. LVSgfp was added at an MOI
of 100 to prechilled TC-1 plates and centrifuged at 300  g for 3 minutes to
synchronize infection as described above. At 10, 20, 30, 60, 120, and 180 min
postinoculation, monolayers were washed with PBS to remove unattached bac-
teria and fixed using 4% PFA. Samples were blocked with PBS-Fc block-5%
donkey serum and incubated with anti-F. tularensis LPS diluted 1:1,000 for 30
min at 4°C followed by donkey anti-mouse AMCA (7-amino-4-methylcoumarin-
3-acetic acid; Jackson ImmunoResearch) diluted 1:100 for 30 min at 4°C to label
extracellular bacteria. For early endosome antigen 1 (EEA1) or lysosome-asso-
ciated membrane protein 1 (LAMP-1), staining samples were blocked using
PBS-0.1% saponin-5% serum of host species of secondary antibody followed by
goat polyclonal anti-EEA1 (N-19; Santa Cruz Biotechnologies) diluted 1:200 in
blocking solution or rat monoclonal anti-mouse LAMP-1 (1D4B; developed by
J. T. August, obtained from the Developmental Studies Hybridoma Bank devel-
oped under the auspices of the NICHD and maintained by The University of
Iowa, Department of Biological Sciences, Iowa City, IA 52242) diluted 1:200 in
blocking solution. Secondary antibodies used were donkey anti-goat Cy5 (Jack-
son ImmunoResearch) or goat anti-rat Alexa Fluor 647 (Molecular Probes)
diluted 1:500 in PBS-0.1% saponin. Samples were examined using a Zeiss
Axioplan 2 epifluorescence microscope and SlideBook digital deconvolution
software (Intelligent Imaging Innovations). One hundred intracellular bacteria
were counted for each time point and condition. Images of sequential vertical
planes were acquired to determine the location of bacteria within EEA1- or
LAMP-1-containing vacuoles. Data presented are the results of three indepen-
dent experiments.
Electron microscopy. Cell monolayers grown on polystyrene plates were rinsed
with PBS or serum-free medium and fixed in 3% glutaraldehyde-0.15 M sodium
phosphate, pH 7.4. Following three rinses with sodium phosphate buffer, the
monolayers were postfixed for 1 h in 1% osmium tetroxide-1.25% potassium
ferrocyanide-0.15 M sodium phosphate buffer, rinsed in deionized water, dehy-
drated using increasing concentrations of ethanol (30%, 50%, 75%, 100%, 100%;
10 min each), and embedded in Polybed 812 epoxy resin (Polysciences, Inc.,
Warrington, PA). The embedded samples were sectioned parallel and perpen-
dicular to the substrate at 70 nm using a diamond knife. Ultrathin sections were
collected on 200-mesh copper grids and stained with 4% aqueous uranyl acetate
for 15 min, followed by Reynolds’ lead citrate for 7 min. Sections were observed
using a Leo EM910 transmission electron microscope at 80 kV (Leo Electron
Microscopy, Thornwood, NY) and photographed using a Gatan Bioscan digital
camera (Gatan, Inc., Pleasanton, CA).
RESULTS
Kinetics of F. tularensis epithelial cell attachment and inva-
sion. Francisella tularensis LVS invades and replicates within
TC-1, MLE 12, and A549 lung epithelial cell lines (21). While
the intracellular replication rates within these lines are indis-
tinguishable, TC-1 cells support the highest initial invasion
frequency (21). In addition, TC-1 cells are a mouse cell line,
and LVS infection causes a tularemia-like disease in mice
similar to that seen with virulent strains in humans. We there-
fore used TC-1 cells to examine the initial stages of F. tularensis
invasion.
2834 CRAVEN ET AL. INFECT. IMMUN.
To determine the kinetics of lung cell attachment and inva-
sion by F. tularensis, we synchronized the infection of TC-1
cells at an MOI of 100 with LVSgfp. At 10, 20, 30, and 60 min
postinoculation, cells were washed to remove nonadherent
bacteria and collected to quantify TC-1 cells associated with
GFP-expressing bacteria by flow cytometry (Fig. 1A). At these
same time points, in parallel samples, extracellular bacteria
were stained using a Pacific Blue-labeled antibody to F. tula-
rensis LPS and TC-1 cells were lysed to recover cell-associated
bacteria. GFP-positive bacteria recovered from cells were an-
alyzed by flow cytometry to determine intracellular (GFP
alone) versus extracellular (GFP and Pacific Blue) localization
(Fig. 1B). At 10 min, 1.7% ( 0.4%) of TC-1 cells had asso-
ciated bacteria, of which 1.4% ( 0.1%) of TC-1 cell-associ-
ated bacteria were intracellular. At 20 min postinoculation,
1.1% ( 0.2%) of TC-1 cells had cell-associated bacteria, of
which 7.0% ( 0.6%) were internal. At 30 min postinocula-
tion, 1.0% ( 0.2%) of TC-1 cells had cell-associated bacteria,
of which 21.3% ( 6.3%) were internal. At 60 min postinocu-
lation, 1.4% ( 0.1%) of TC-1 cells had cell-associated bacte-
ria, of which 23.6% ( 5.8%) were intracellular.
To determine if LVS entry into lung epithelial cells required
viable bacteria, we repeated the above-described experiments
using killed LVSgfp. At 10 min, 0.9% ( 0.2%) of TC-1 cells
had dead bacteria associated with them, of which 1.2% ( 0.4%)
of TC-1 cell-associated bacteria were intracellular. At 20 min
postinoculation, 1.1% ( 0.7%) of TC-1cells had cell-associ-
ated dead bacteria, of which 5.7% ( 0.6%) were internal. At
30 min postinoculation, 0.6% ( 0.2%) of TC-1 cells had
cell-associated dead bacteria, of which 17.3% ( 3.5%) were
internal. At 60 min postinoculation, 0.4% ( 0.1%) of cells
had dead bacteria associated with them, of which 25.7%
( 1.6%) were intracellular. These results indicated that both
live and dead LVS attached to and invaded lung epithelial
cells. Further, invasion frequency and kinetics were not signif-
icantly different between live and dead bacteria (P  0.01),
except for cell association at 60 min (Fig. 1). The ability of
nonviable F. tularensis to invade lung epithelial cells suggested
that a preformed ligand on the bacterial surface may interact
with the host cell.
Effects of cytoskeleton and signaling pathway inhibitors on
F. tularensis invasion of epithelial cells. Inhibitors of eukary-
otic cell function were used to determine the contribution of
host cell signaling and cytoskeleton rearrangement to LVS
invasion of lung epithelial cells. Bacterial entry into host cells
generally requires rearrangement of cytoskeletal structures;
either microfilaments alone, as is the case with Salmonella,
Shigella, Listeria, and Yersinia spp. (12), or both microfilaments
and microtubules, as is the case with Neisseria gonorrhoeae and
Campylobacter jejuni (4, 43).
To determine the contribution of actin polymerization to
LVS invasion, we incubated TC-1 lung epithelial cells with
cytochalasin D, an actin polymerization inhibitor that disrupts
microfilaments, and measured bacterial internalization by gen-
tamicin protection assay. Treatment of TC-1 cells with 0.5 and
1.0 M cytochalasin D decreased LVS invasion more than
99% ( 0.1%) (Fig. 2A), whereas Salmonella enterica invasion,
which is known to be actin dependent (36), decreased by 84.6%
( 2.3%) and 88.1% ( 2.5%) at the same inhibitor concen-
trations, respectively. TC-1 cell invasion by Campylobacter
jejuni strain 81-176, a strain which does not require actin for
invasion of intestinal epithelial cells (34), was not decreased by
actin inhibition.
Microtubules are responsible for the cytoplasmic organiza-
tion of eukaryotic cells and the control of organelle transport
and are a primary component of cilia and flagella (55). Micro-
tubule polymerization has been shown to contribute to the
epithelial cell invasion of Neisseria gonorrhoeae and Campy-
lobacter jejuni (4, 43). To determine the contribution of micro-
tubules to LVS invasion, we treated lung epithelial cells with
colchicine, which binds tubulin and inhibits microtubule poly-
merization, and determined invasion by gentamicin protection
assay. Treatment of TC-1 cells with colchicine decreased LVS
invasion by 55.2% ( 18.3%) and 94.2% ( 2.4%) at 0.1 and
0.25 M concentrations, respectively (Fig. 2B). TC-1 cell in-
vasion by Campylobacter jejuni strain 81-176, a strain for which
invasion is blocked by microtubule depolymerization in intes-
tinal epithelial cells (34), was decreased significantly at the
higher colchicine concentration. Salmonella enterica invasion,
which is not considered microtubule dependent (4), did not
FIG. 1. F. tularensis LVS association with and internalization by
TC-1 lung epithelial cells. (A) Percentage of TC-1 cells with associated
live or PFA-fixed LVS at designated times postinoculation. *, Data are
significantly different from untreated control data (P  0.01 by paired
two-tailed t test). (B) Percentages of TC-1 cell-associated live or PFA-
fixed LVS that are intracellular at the designated times postinocula-
tion.
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demonstrate a statistically significant decrease in invasion at
these concentrations.
Signaling pathways are frequently manipulated by bacte-
ria to cause the cytoskeletal rearrangement necessary to
gain entry into nonphagocytic cells (10, 15, 16). PI 3-kinase
and tyrosine kinase signaling are exploited by other patho-
gens for invasion (25, 45). These pathways were examined
for their contribution to Francisella tularensis entry into lung
epithelial cells.
PI 3-kinases phosphorylate inositol phospholipids, form-
ing lipid products that are in turn involved in cellular func-
tions such as cell growth, actin rearrangement, and vesicular
trafficking (51). To determine the importance of PI 3-kinase
signaling to F. tularensis invasion, lung epithelial cells were
treated with wortmannin, an inhibitor of PI 3-kinase activity,
and invasion was assessed by gentamicin protection assay.
Wortmannin decreased LVS invasion of TC-1 cells by 69.4%
( 4.6%) and 84.1% ( 1.8%) when cells were exposed to
100 and 200 nM concentrations, respectively (Fig. 3A). In-
vasion by Listeria monocytogenes, which is PI 3-kinase de-
pendent (25), was significantly decreased. Salmonella en-
terica invasion, which is not PI 3-kinase dependent (49), was
not significantly decreased at these concentrations in TC-1
cells.
Cells monitor and respond to their external environment
via receptors that lead to intracellular signaling events (53).
Activation of receptor tyrosine kinases can lead to receptor
internalization as well as the initiation of a cascade of down-
stream signaling events (53). Some organisms, such as Yer-
sinia pseudotuberculosis, exploit signaling through host cell
receptors to gain entry into cells, and this entry can be
blocked by tyrosine kinase inhibitors (45). To determine the
contribution of tyrosine kinase signaling to LVS invasion,
the inhibitor genistein was added to lung epithelial cells and
the number of intracellular organisms measured by genta-
micin protection assay. Genistein decreased LVS invasion of
TC-1 cells by 68.1% ( 1.1%) and 77.1% ( 1.1%) at 50 and
100 M concentrations, respectively (Fig. 3B). Invasion by
Yersinia pseudotuberculosis was significantly reduced at these
concentrations, while Salmonella enterica invasion, which is
tyrosine kinase independent (45), was not significantly de-
creased in TC-1 cells.
Collectively, these results indicate that actin and microtu-
bule rearrangement both contribute to the entry of F. tularensis
into lung epithelial cells. PI 3-kinase and tyrosine kinase, pro-
teins which regulate cytoskeletal rearrangement, both impact
F. tularensis invasion of lung epithelial cells.
LVS traffics along the endocytic pathway in lung epithelial
cells. To characterize the trafficking of F. tularensis LVS along
the endocytic pathway in lung epithelial cells, we synchronized
the addition of LVSgfp to TC-1 cells and evaluated these cells
microscopically for the presence of bacteria inside vacuoles
containing the early endosomal marker EEA1 or the late en-
dosomal/lysosomal marker LAMP-1 (Fig. 4A and B). LVS
association with EEA1-containing phagosomes increased from
1.4% ( 2.4%) at 10 min to 40.4% ( 5.3%) at 30 min before
decreasing (Fig. 4C). LVS association with LAMP-1-containing
vacuoles peaked 2 hours postinoculation at 49.3% ( 3.5%) (Fig.
FIG. 2. The effect of actin and microtubule polymerization on F. tularensis LVS invasion of lung epithelial cells. TC-1 cells were treated with
designated concentrations of cytochalasin D (A) or colchicine (B). Results are expressed as the percentage of LVS, Salmonella, or Campylobacter
organisms that survived gentamicin treatment relative to that for the sample without inhibitor inoculated with the same organism (defined as 100%
invasion). *, Data are significantly different from untreated control data (P  0.01 by paired two-tailed t test).
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4C). These results indicate that LVS traffics along the endo-
cytic pathway in lung epithelial cells, associating first with early
endosomes before progressing to late endosomes/lysosomes.
LVS escapes the phagosome and replicates in the cytoplasm
of lung epithelial cells. Once inside host cells, invasive bacteria
either replicate within the endosome or escape the vacuole and
replicate in the cytoplasm. To determine the intracellular lo-
cation of bacteria, TC-1 cells were inoculated with LVS at an
MOI of 100 and examined at 1 and 24 h by transmission
electron microscopy. At 1 h postinoculation, LVS were con-
tained within TC-1 cells in a membrane-bound vacuole (Fig.
5A). The membrane was easily visualized and in some cases
was beginning to degrade (Fig. 5A). By 24 h, all observed
intracellular bacteria were no longer contained within a visible
membrane and appeared to be free in the cytoplasm (Fig. 5B),
though they were surrounded by an electron-lucent zone that
has been noted by other researchers (8, 19).
To determine the kinetics of LVS escape from the endocytic
pathway into the cytoplasm of lung epithelial cells, we differ-
entially labeled extracellular, cytoplasmic, and vacuolar LVSgfp
and analyzed recovered bacteria by flow cytometry (modified
from the technique of Checroun et al. [reference 7]). We first
labeled bacteria that were extracellular and attached to TC-1
cells by use of Pacific Blue-conjugated anti-F. tularensis LPS.
We then permeabilized the cytoplasmic membrane of TC-1
cells by use of digitonin, allowing Alexa Fluor 647-conjugated
anti-F. tularensis LPS to access cytoplasmic bacteria, but not
those enclosed in intact vacuoles, which are digitonin imper-
meable. TC-1 cells were lysed and cell-associated bacteria re-
covered and analyzed by flow cytometry, gating on GFP to
differentiate bacteria from residual TC-1 debris. The resulting
three populations of bacteria were analyzed: extracellular (Pa-
cific Blue, Alexa Fluor 647, and GFP), cytoplasmic (Alexa
Fluor 647 and GFP), and vacuolar (GFP only) (Fig. 6A and B).
At 10 min postinoculation, 19.3% ( 8.1%) of intracellular
bacteria were accessible to antibody delivered to the cytoplasm
and therefore were considered cytoplasmic (Fig. 6C). This
number increased to 70.0% ( 5.5%) at 2 h postinoculation,
indicating that the majority of intracellular bacteria were no
longer contained within intact endocytic vacuoles. It should be
noted that once the vacuolar membrane begins to degrade,
bacteria are accessible to antibody. As a result, bacteria that
were associated with LAMP-1-staining vacuoles at 2 h posti-
noculation (Fig. 4C) would be identified as cytoplasmic by
this assay if the vacuolar membrane was no longer intact.
When TC-1 cells were treated with saponin, which perme-
abilizes both vacuolar and cytoplasmic membranes, greater
than 99% of bacteria were accessible to antibody labeling
(data not shown), demonstrating that a population of bac-
teria were protected from staining when only the cytoplas-
mic membrane was permeabilized. Microscopic examination
of saponin-treated TC-1 cells revealed that anti-F. tularensis
antibody was able to access bacteria in EEA1-containing
vacuoles, while antibody was excluded from these vacuoles
FIG. 3. The effect of PI 3-kinase and tyrosine kinase activity on LVS invasion of lung epithelial cells. Wortmannin (A) and genistein (B) were
added to TC-1 cells at the indicated concentrations. Results are expressed as the percentage of LVS or control organisms that survived gentamicin
treatment relative to that for the sample without inhibitor inoculated with the same organism (defined as 100% invasion). *, Data are significantly
different from untreated control data (P  0.01 by paired two-tailed t test).
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in digitonin-treated cells (data not shown). When TC-1 cells
were inoculated with PFA-killed bacteria, 90% of organ-
isms were vacuolar at 60 min postinoculation, indicating that
killed bacteria did not escape into the cytoplasm (data not
shown). Thus, bacterial viability was required for escape
from the epithelial cell endosome.
DISCUSSION
The ability of many facultative intracellular bacterial patho-
gens to cause disease is dependent upon their ability to invade
and replicate within various host cells (14, 22, 41). F. tularensis
survival and replication within macrophages and dendritic cells
has been well described (1, 5, 6, 8, 33). We previously demon-
strated that F. tularensis LVS also localizes to and replicates
within ATII epithelial cells following inhalation of organisms
in a mouse model of infection (21), prompting us to investigate
lung epithelial cell invasion by this organism.
ATII cells account for about 12% of the total cells, and 2%
of the surface area, of the alveolar region in mice (50). Ap-
proximately 98% of the surface area, and 10% of the total cell
number, is comprised of type I cells, which provide structure
and are the site of gas exchange (50). Type II cells have a
number of biological functions, including the production, se-
cretion, and recycling of surfactant; proliferation to produce
additional type II cells as well as transdifferentiation into type
I cells; maintenance of alveolar fluid balance; and production
of antimicrobial and anti-inflammatory substances (29). Due to
their close proximity to endothelial cells and their role in gas
exchange and fluid balance, these cells are ideally located to
provide a portal through which bacteria could disseminate to
distal organs.
To characterize the interactions of F. tularensis with lung
epithelial cells, we investigated the initial interactions of
LVS with the lung epithelial cell line TC-1. We determined
that bacteria associated with and were internalized by lung
epithelial cells within 10 min of inoculation and that viable
bacteria were not necessary for gaining entry into these
cells. We previously found that the frequency with which F.
tularensis invaded lung epithelial cell lines was low (21). The
low invasion frequency may be due to the inherent inability
of a transformed cell line grown in a nonpolarized fashion to
recapitulate the complex environment within the host lung.
These cells may also intermittently express a relevant recep-
tor or other process that facilitates F. tularensis invasion in
vivo. A system using primary cells grown in a polarized
manner may more realistically reproduce the environment
in the lung (18). Given the quantity of cells required for
studies, cell culture lines provide a reasonable place to begin
FIG. 4. Representative fluorescence microscopy images demonstrating LVSgfp localization within EEA1- or LAMP-1-containing endosomes
in TC-1 cells. Images depict TC-1 cells stained for EEA1 30 min after inoculation with LVSgfp (A) or 2 h postinoculation stained for LAMP-1
(B). Single-color images: LVSgfp images depict bacteria alone, EEA1 and LAMP-1 images depict staining for EEA1 or LAMP-1 only, and
extracellular images depict staining of extracellular bacteria (no extracellular bacteria were present in panel B). The merged color images depict
LVSgfp (green), vacuoles labeled with anti-EEA1 antibody (N19) (red) or anti-LAMP-1 (1D4B) (red), or extracellular LVS labeled with anti-F.
tularensis LPS antibody conjugated to Pacific Blue (blue). Extracellular LVSgfp (arrow with round end), intracellular but not EEA1-associated
LVSgfp (small arrow), and LVS associated with EEA1-containing vacuoles (large arrowhead). (C) Trafficking of LVSgfp in TC-1 cells. One
hundred intracellular bacteria were counted for each condition and scored for association with EEA1- and LAMP-1-containing vacuoles. Three
replicates were examined for each time point and condition.
FIG. 5. Transmission electron micrographs of TC-1 infected with
F. tularensis LVS. (A) TC-1 cells 1 h postinoculation showing LVS in
a membrane-bound vacuole that in some cases appeared to be degrad-
ing (arrow). (B) LVS cells 24 h postinoculation were free in the
cytoplasm.
FIG. 6. LVSgfp was analyzed by flow cytometry for escape from
vacuoles into the cytoplasm of TC-1 cells. Extracellular bacteria were
labeled with anti-F. tularensis LPS antibody conjugated to Pacific Blue
(region R8). Cytoplasmic bacteria were identified by labeling with
anti-F. tularensis LPS conjugated to Alexa Fluor 647 after digitonin
permeabilization of the cytoplasmic membrane (region R10). Vacuolar
bacteria were inaccessible to antibody and therefore GFP positive only
(region R9). Representative flow cytometry data of bacteria recovered
10 min (A) or 60 min (B) postinoculation. The value shown in region
R10 represents the percentage of intracellular bacteria that are cyto-
plasmic. (C) Percentages of intracellular bacteria present in the cyto-
plasm at designated times postinoculation.
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the investigation of the interaction of bacteria with epithe-
lial cells and have been described as a model for such in-
teractions (28).
Pathogens have developed numerous means of exploiting
host cell functions to gain entry into nonphagocytic cells (10,
15). These invasion strategies are typically classified as ei-
ther a zipper mechanism, which is utilized by pathogens such
as Yersinia pseudotuberculosis and Listeria monocytogenes, or
a trigger mechanism, which is utilized by organisms such as
Salmonella enterica serovar Typhimurium and Shigella flex-
neri. The zipper mechanism is characterized by bacterial
surface proteins binding to host cell receptors, leading to
internalization. The trigger mechanism is characterized by
the injection of bacterial effector proteins into the host cell
via a type III secretion system, resulting in bacterial engulf-
ment via induced macropinocytosis. Entry by either of these
mechanisms requires the manipulation of host cell cytoskel-
etal components and signaling pathways. A number of host
cell receptors play a role in F. tularensis entry into macro-
phages, including Fc, complement receptor 3, macrophage
mannose receptor, and class A scavenger receptors (3, 38,
47). However, very little is known about how this organism
is able to access cells that are not considered to be profes-
sional phagocytes.
To better understand the process of F. tularensis entry into
lung epithelial cells, we investigated cytoskeletal components
and signaling pathways that are involved in epithelial invasion
by other bacterial pathogens for their contribution to internal-
ization of LVS by a lung epithelial cell line. Lindemann et al.
previously demonstrated that actin and microtubules are nec-
essary for F. tularensis invasion of the human epithelial cell line
HEp-2 (28). We determined that both actin and microtubules
contribute to F. tularensis invasion of lung epithelial cells, as do
PI 3-kinases and tyrosine kinases, both of which can control
signaling events leading to cytoskeletal rearrangement. We
showed that F. tularensis internalization by lung epithelial cells
is dependent upon a variety of host cell mechanisms and that
interruption of any of these mechanisms interferes with bac-
terial invasion.
We were unable to identify the characteristic membrane
ruffling that is seen with Salmonella invasion either by phal-
loidin staining or field emission scanning electron micros-
copy under conditions where we were able to clearly identify
membrane ruffling with Salmonella (data not shown). While
this points toward F. tularensis not causing massive actin
reorganization at the site of entry, it is possible that mem-
brane ruffling occurs but was not detected by us. Listeria
monocytogenes, another organism that is able to invade ep-
ithelial cells, also requires PI 3-kinase and tyrosine kinase
function for invasion, in a cell-type-dependent manner (39,
40). This organism has two invasion proteins, InlA and InlB,
which interact with different host receptors, leading to dif-
ferent signaling events. It is possible that F. tularensis also
uses multiple receptors for entry into lung epithelial cells
and that interruption of various signaling pathways could
decrease uptake via various receptors. Toll-like receptors
(TLRs) may play a role in the modulation of the immune
response to F. tularensis (9, 23, 54), and functional TLRs are
present on ATII cells (2). However, TLRs have not been
implicated among macrophage receptors for F. tularensis
internalization identified to date (3, 38, 47). Melillo et al.
have reported that E. coli expressing the F. tularensis surface
protein FsaP was able to bind A549 cells (31). We have also
demonstrated that killed F. tularensis was taken up by lung
epithelial cells. This information, taken together with the
absence of genes predicted to encode a type III secretion
system, points toward the presence of a preformed ligand
receptor interaction, as with the zipper mechanism of up-
take, rather than the injection into the host cell of effector
proteins, as with organisms that gain entry via the trigger
mechanism. Further studies are needed to identify receptors
necessary for the uptake of F. tularensis by nonphagocytic
cells.
To investigate F. tularensis trafficking along the endocytic
pathway in lung epithelial cells, we examined the association of
LVS with EEA1- and LAMP-1-containing vacuoles as well as
escape into the cytoplasm. F. tularensis traffics along the endo-
cytic pathway in macrophages before escaping to the cyto-
plasm, where replication occurs. The timing of this escape
seems to be dependent upon the Francisella species and host
cell type tested. “F. tularensis subsp. novicida” begins to disrupt
the phagosomal membrane of quiescent human macrophages
at 4 h and is free in the cytoplasm by 12 h postinfection (46).
LVS and clinical isolates of F. tularensis associate with EEA1-
and then LAMP-1-containing vacuoles in mouse bone marrow-
derived macrophages, human macrophages, and mouse and
human macrophage-like cell lines before degrading the pha-
gosomal membrane and beginning to escape into the cyto-
plasm between 1 and 2 hours postinoculation (7, 8, 19). We
determined that LVS was initially associated with EEA1-con-
taining vacuoles, and then with LAMP-1-containing vacuoles,
before being found free in the cytoplasm of lung epithelial cells
in a manner and kinetic consistent with that seen for macro-
phages.
F. tularensis LVS is found in ATII cells in the lungs of
C57BL/6 mice 1, 3, and 7 days after intranasal inoculation and
replicates in these cells as disease progresses. By day 7 organ-
isms are widespread in the alveolar epithelium (21). These
observations demonstrate that that ATII cell invasion and
replication is a part of the F. tularensis disease process.
Understanding how this bacterium gains access to these
cells, and just as importantly, how it replicates and estab-
lishes a stronghold in the lung epithelium, is necessary to
understanding the progression of respiratory tularemia, as
well as potentially providing insight into methods that may
be used to block bacterial uptake or replication and thus
prevent disease.
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